| __timestamp | Exelixis, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 382096000000 |
| Thursday, January 1, 2015 | 96351000 | 345927000000 |
| Friday, January 1, 2016 | 95967000 | 312303000000 |
| Sunday, January 1, 2017 | 112171000 | 325441000000 |
| Monday, January 1, 2018 | 182257000 | 368298000000 |
| Tuesday, January 1, 2019 | 336964000 | 492381000000 |
| Wednesday, January 1, 2020 | 547851000 | 455833000000 |
| Friday, January 1, 2021 | 693716000 | 526087000000 |
| Saturday, January 1, 2022 | 891813000 | 633325000000 |
| Sunday, January 1, 2023 | 1044071000 | 729924000000 |
| Monday, January 1, 2024 | 910408000 | 729924000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Takeda Pharmaceutical Company Limited and Exelixis, Inc. have demonstrated distinct strategies in their R&D allocations. Takeda, a global leader, consistently invested heavily, with a notable 91% increase from 2014 to 2023, peaking at approximately 730 billion yen in 2023. In contrast, Exelixis, a smaller biotech firm, showed a remarkable growth trajectory, with R&D expenses surging by over 450% during the same period, reaching around 1 billion dollars in 2023. This stark contrast highlights the diverse approaches within the industry, where established giants and agile innovators both play pivotal roles. Notably, data for 2024 is incomplete, indicating potential shifts in future strategies. These insights underscore the dynamic nature of pharmaceutical R&D investments, shaping the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Exelixis, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and argenx SE
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Genmab A/S
R&D Insights: How Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Axsome Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Geron Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Mesoblast Limited Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Exelixis, Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and Exelixis, Inc. Allocate Funds
Exelixis, Inc. or Opthea Limited: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Exelixis, Inc. vs Perrigo Company plc